Target intelligence / Profile preview

FAST kinase domain-containing protein 1, mitochondrial (FASTKD1)

Target
FASTKD1
Molecular classification
RNA-binding protein, Mitochondrial protein, Post-transcriptional regulator, FAST kinase family member
01

Overview

FAST kinase domain-containing protein 1, mitochondrial (FASTKD1), is a member of the FAST kinase family of RNA-binding proteins localized to mitochondria, where it plays key roles in mitochondrial RNA processing, stability, and post-transcriptional regulation of gene expression. FASTKD1 regulates levels of mitochondrial-encoded ND3 mRNA and negatively modulates complex I activity, with its activity dependent on the RAP domain. It is involved in biological processes such as cell cycle control, apoptosis, and the cellular response to stress, including oxidative stress and the integrated stress response in cardiac tissue. Elevated expression of FASTKD1 has been observed in multiple cancer types and in cardiovascular disease contexts, making it a candidate diagnostic and prognostic biomarker, with potential therapeutic relevance. Genomic alterations of FASTKD1 have been linked to modulation of immune cell infiltration and tumor microenvironment, with further implications noted for neurodegenerative and developmental disorders. Its molecular mechanisms, particularly regarding interactions with potential drugs, remain to be fully elucidated.

Other names
FASTKD1KIAA1800FLJ21901FAST kinase domain-containing protein 1, mitochondrial
02

Mechanism of action

Not established for drugs; functions through RNA-binding and regulation of mitochondrial mRNA stability, mainly via its RAP domain affecting MT-ND3 mRNA levels and complex I activity

03

Biological functions

Mitochondrial RNA processing and stabilityRegulation of mitochondrial gene expressionNegative regulation of complex I activity in mitochondriaCell cycle regulationModulation of the integrated stress responseRegulation of apoptosis and cell death pathwaysResponse to oxidative stress
04

Disease associations

Cancer (elevated expression in various carcinomas; role in tumorigenesis, prognosis marker)Cardiovascular disease (protective role post-myocardial infarction)Neurodegenerative disease (implicated through genomic alterations)Other diseases with copy number variations affecting immune response
05

Safety considerations

None specifically identified; changes in FASTKD1 CNV may impact genomic stability, immune infiltration, and disease progression in cancer
06

Biomarkers

Diagnostic and prognostic biomarker for stomach adenocarcinoma (STAD) and possibly other cancers

Beyond the preview

Go deeper on FAST kinase domain-containing protein 1, mitochondrial (FASTKD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FAST kinase domain-containing protein 1, mitochondrial (FASTKD1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call